VYGR vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 13, 2026

VYGR

49.6
AI Score
VS
CBIO Wins

CBIO

51.4
AI Score

Investment Advisor Scores

VYGR

50score
Recommendation
BUY

CBIO

51score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric VYGR CBIO Winner
Forward P/E 8.4388 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -70.0% 0.0% CBIO
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 49.6/100 51.4/100 CBIO
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation BUY BUY Tie

Relative Price Performance (Last 90 Days)

VYGR 1M: -15.4% · 3M: -48.0% CBIO 1M: +14.2% · 3M: -16.2%

Current Technical Phase

VYGR

Markdown
Sell / avoid

Price below a falling SMA50 (slope -19.9%), weak momentum, RSI 37

RSI (14): 37.3 · Price: $1.70

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 54.3 · Price: $14.37

Fundamentals Snapshot

Metric VYGR CBIO
Market Cap — —
Forward P/E -1.3 -5.5
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.7% 0.0%
Gross Margin -3.2% 1.0%
Operating Margin -4.4% -14.3%
EPS -1.74 -7.20
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CBIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.